Risk of Dementia in Long-Term Benzodiazepine Users: Evidence from a Meta-Analysis of Observational Studies
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background and Purpose There is conflicting evidence in the literature on the association between benzodiazepines (BDZs) and the risk of dementia.This meta-analysis aimed to determine the relationship between the long-term usage of BDZs and the risk of dementia. MethodsThe PubMed and Embase databases were systematically searched for relevant publications up to September 2017.The literature search focused on observational studies that analyzed the relationship between the long-term use of BDZs and the risk of dementia.Pooled rate ratios (RRs) with 95% confidence interval (CI) were assessed using a random-effects model.The robustness of the results was checked by performing subgroup and sensitivity analyses. ResultsTen studies were included: six case-control and four cohort studies.The pooled RR for developing dementia was 1.51 (95% CI=1.17-1.95,p=0.002) in patients taking BDZ.The risk of dementia was higher in patients taking BDZs with a longer half-life (RR=1.16,95% CI= 0.95-1.41,p=0.150) and for a longer time (RR=1.21,95% CI=1.04-1.40,p=0.016).Conclusions This meta-analysis that pooled ten studies has shown that BDZ significantly increases the risk of dementia in the elderly population.The risk is higher in patients taking BDZ with a longer half-life (>20 hours) and for a longer duration (>3 years).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interaction revisited: the difference between two estimates.
Altman, D. G., & Bland, J. M. (2003) · BMJ · doi:10.1136/bmj.326.7382.219 · Cited by 3,203
Lyketsos, C. G., Lopez, O., Jones, B., Fitzpatrick, A. L., Breitner, J., & DeKosky, S. (2002) · JAMA · doi:10.1001/jama.288.12.1475 · Cited by 2,049
A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
Doody, R. S., Raman, R., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., He, F., Sun, X., Thomas, R. G., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1210951 · Cited by 1,224
GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease
Jo, S., Yarishkin, O., Hwang, Y. J., Chun, Y. E., Park, M., Woo, D. H., Bae, J. Y., Kim, T., Lee, J., Chun, H., et al. (2014) · Nature Medicine · doi:10.1038/nm.3639 · Cited by 783
Prodromal Alzheimer's disease: successive emergence of the clinical symptoms
Amieva, H., Le Goff, M., Millet, X., Orgogozo, J. M., Pérès, K., Barberger‐Gateau, P., Jacqmin‐Gadda, H., & Dartigues, J. F. (2008) · Annals of Neurology · doi:10.1002/ana.21509 · Cited by 737
Gray, S. L., Dublin, S., Yu, O., Walker, R., Anderson, M., Hubbard, R. A., Crane, P. K., & Larson, E. B. (2016) · BMJ · doi:10.1136/bmj.i90 · Cited by 233
Benzodiazepines and Injurious Falls in Community Dwelling Elders
Pariente, A., Dartigues, J.-F., Benichou, J., Letenneur, L., Moore, N., & Fourrier-Réglat, A. (2008) · Drugs & Aging · doi:10.2165/00002512-200825010-00007 · Cited by 172
Research works printed but not linked: 22
- Griffin, 2013, Ochsner J, 13, 214
- Gallacher, 2012, J Epidemiol Community Health, 66, 869, 10.1136/jech-2011-200314 · DOI · Paper page
- Wu, 2011, Am J Geriatr Psychiatry, 19, 151, 10.1097/JGP.0b013e3181e049ca · DOI
- Wu, 2009, Am J Geriatr Psychiatry, 17, 614, 10.1097/JGP.0b013e3181a65210 · DOI
- Lagnaoui, 2002, J Clin Epidemiol, 55, 314, 10.1016/S0895-4356(01)00453-X · DOI
- Billioti de Gage, 2012, BMJ, 345, e6231, 10.1136/bmj.e6231 · DOI · Paper page
- Gomm, 2016, J Alzheimers Dis, 54, 801, 10.3233/JAD-151006 · DOI · Paper page
- Shash, 2016, Alzheimers Dement, 12, 604, 10.1016/j.jalz.2015.10.006 · DOI · Paper page
- Imfeld, 2015, Drug Saf, 38, 909, 10.1007/s40264-015-0319-3 · DOI
- Chan, 2017, Psychogeriatrics, 17, 310, 10.1111/psyg.12239 · DOI · Paper page
- Begg, 1994, Biometrics, 50, 1088, 10.2307/2533446 · DOI · Paper page
- Golder, 2013, PLoS One, 8, e71813, 10.1371/journal.pone.0071813 · DOI
- Imbimbo, 2011, Curr Top Med Chem, 11, 1555, 10.2174/156802611795860942 · DOI · Paper page
- May, 1993, Neurosci Lett, 152, 169, 10.1016/0304-3940(93)90510-R · DOI
- Pariente, 2016, CNS Drugs, 30, 1, 10.1007/s40263-015-0305-4 · DOI
- Zhang, 2016, Alzheimer Dis Assoc Disord, 30, 113, 10.1097/WAD.0000000000000099 · DOI
- Taragano, 2009, J Clin Psychiatry, 70, 584, 10.4088/JCP.08m04181 · DOI · Paper page
- Rossat, 2011, J Nutr Health Aging, 15, 72, 10.1007/s12603-011-0015-7 · DOI · Paper page
- Díaz-Gutiérrez, 2017, Maturitas, 101, 17, 10.1016/j.maturitas.2017.04.002 · DOI · Paper page
- Fastbom, 1998, Alzheimer Dis Assoc Disord, 12, 14, 10.1097/00002093-199803000-00002 · DOI · Paper page
- Chen, 2012, PLoS One, 7, e49113, 10.1371/journal.pone.0049113 · DOI · Paper page
- Billioti de Gage, 2014, BMJ, 349, g5205, 10.1136/bmj.g5205 · DOI · Paper page
Cited by
De Crescenzo, F., D'Alò, G. L., Ostinelli, E. G., Ciabattini, M., Di Franco, V., Watanabe, N., Kurtulmus, A., Tomlinson, A., Mitrova, Z., Foti, F., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00878-9 · Cited by 446
Understanding the effects of chronic benzodiazepine use in depression: a focus on neuropharmacology
Lim, B., Sproule, B. A., Zahra, Z., Sunderji, N., Kennedy, S. H., & Rizvi, S. J. (2020) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000316 · Cited by 50
Dyer, A. H., Murphy, C., Lawlor, B., Kennelly, S. P., Lawlor, B., Segurado, R., Kennelly, S., Olde Rikkert, M. G. M., Howard, R., Pasquier, F., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.08.006 · Cited by 39
Caldiroli, A., Capuzzi, E., Tagliabue, I., Ledda, L., Clerici, M., & Buoli, M. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2159373 · Cited by 2
Metadata
- Authors
- He, Q., Chen, X., Wu, T., Li, L., & Fei, X.
- Venue
- Journal of Clinical Neurology
- Publisher
- Korean Neurological Association
- Published
- 2019
- Volume
- 15
- Issue
- 1
- Pages
- 9
- ISSN
- 1738-6586 (ISSN-L)
- 2005-5013
- OpenAlex
- W2904873292
- Cited by
- 95
- References
- 7
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- diamond
- Licence
- creativecommons.org/licenses/by-nc/4.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk of Dementia in Long-Term Benzodiazepine Users: Evidence from a Meta-Analysis of Observational Studies. https://app.cochat.ai/papers/10.3988/jcn.2019.15.1.9
- The paper
- He, Q., Chen, X., Wu, T., Li, L., & Fei, X. (2019). Risk of Dementia in Long-Term Benzodiazepine Users: Evidence from a Meta-Analysis of Observational Studies. Journal of Clinical Neurology. https://doi.org/10.3988/jcn.2019.15.1.9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.